Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models

Parkinsonism & Related Disorders
Simona PetrucciEnza Maria Valente

Abstract

The identification of the p.A53T mutation in the SNCA gene encoding alpha-synuclein (alpha-syn), as causative of autosomal dominant Parkinson disease (PD) represented a fundamental milestone, which paved the way to the extremely prolific field of PD genetics. Despite being the oldest player in this field and only a rare cause of inherited PD, research on alpha-syn has remained incredibly active over nearly twenty decades, leading to identify alpha-syn aggregation as a key mechanism in PD pathogenesis. The past two years have witnessed new exciting findings, with the discovery of at least three novel pathogenic mutations (p.H50Q, p.G51D and p.A53E) causative of complex parkinsonian phenotypes, and the identification of additional patients carrying "old" SNCA mutations (p.A53T, p.A30P, p.E46K and whole gene multiplications), which has allowed to further expand their phenotypic spectrum. This review aims at providing a clinical and functional update on the most recent findings in alpha-syn genetics, at the same time discussing novel avenues of SNCA research such as those on somatic mutations and epigenetic mechanisms.

References

Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Leonidas Stefanis
Sep 25, 2012·Parkinsonism & Related Disorders·Beatriz TijeroJuan Jose Zarranz
Feb 22, 2013·Neurology·Christos ProukakisAnthony H Schapira
May 16, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Meike Kasten, Christine Klein
Jun 8, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Antonio E EliaEnza Maria Valente
Aug 7, 2013·Parkinsonism & Related Disorders·Dorota Hoffman-ZacharskaAndrzej Friedman
Nov 23, 2013·Parkinsonism & Related Disorders·Heather McCannGlenda M Halliday
Apr 29, 2014·Ageing Research Reviews·Hao Deng, Lamei Yuan
Jan 3, 2015·Neurobiology of Aging·Wei XuJin-Tai Yu
Mar 31, 2015·Parkinsonism & Related Disorders·Márcia M G PimentelCíntia B Santos-Rebouças
Jun 17, 2015·Parkinsonism & Related Disorders·Simone OlgiatiVincenzo Bonifati

❮ Previous
Next ❯

Citations

Dec 29, 2015·Biochemical and Biophysical Research Communications·Leonid BreydoWenxin Wang
Jun 16, 2016·Lancet Neurology·Bryan Maloney, Debomoy K Lahiri
Jul 15, 2016·Brain : a Journal of Neurology·Rimona S WeilHuw R Morris
Oct 30, 2016·Neurobiology of Aging·Viorica ChelbanHenry Houlden
Jan 12, 2017·ACS Chemical Neuroscience·Liang XuDamien Thompson
Mar 24, 2018·Annals of the New York Academy of Sciences·Irma Järvelä
Feb 19, 2017·Cold Spring Harbor Perspectives in Medicine·Robert L Nussbaum
Oct 13, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Li GuoM Francesca Cordeiro
Mar 28, 2019·Open Biology·Anita Krisko, Miroslav Radman
Oct 24, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Hideki HayakawaKousuke Baba
Jan 22, 2020·Chembiochem : a European Journal of Chemical Biology·Jessica D FlynnJennifer C Lee
Mar 24, 2016·Journal of Parkinson's Disease·Diane M A SwallowUNKNOWN PRoBaND Clinical Consortium
Apr 19, 2017·Proceedings of the National Academy of Sciences of the United States of America·Georgia KouroupiRebecca Matsas
Dec 2, 2017·The Journal of Biological Chemistry·Jessica D FlynnJennifer C Lee
May 24, 2018·Current Neurology and Neuroscience Reports·Alessio Di FonzoRoberto Erro
Feb 11, 2019·Current Neurology and Neuroscience Reports·Matthias HöllerhageGünter U Höglinger
Feb 7, 2020·Science Translational Medicine·Na ZhaoGuojun Bu
May 10, 2017·Neurotoxicity Research·Patricia S Muñoz, Juan Segura-Aguilar
Jan 11, 2017·Acta Neuropathologica Communications·Daniel YsselsteinJean-Christophe Rochet
Jul 27, 2017·Scientific Reports·Jenny-Ann PhanMarina Romero-Ramos
Jul 11, 2018·Cell Death & Disease·Natascha FussiGünter U Höglinger
Sep 22, 2018·Nature Reviews. Molecular Cell Biology·Matthew G IadanzaSheena E Radford
Nov 16, 2019·Cell Death & Disease·Goutham K GanjamCarsten Culmsee
Oct 1, 2020·International Journal of Molecular Sciences·Georgia KouroupiRebecca Matsas
Mar 16, 2017·Communicative & Integrative Biology·Anna Villar-PiquéTiago Fleming Outeiro
Sep 10, 2020·Molecular Neurodegeneration·Natalie LandeckJean-Christophe Rochet
Mar 12, 2017·Journal of Parkinson's Disease·Robert L Nussbaum
Jun 20, 2018·Brain : a Journal of Neurology·Katya MokretarChristos Proukakis
Oct 9, 2020·The Journal of Biological Chemistry·Stephanie J GuineyScott Ayton
Jan 18, 2021·The Journal of Biological Chemistry·Stephanie J GuineyScott Ayton
May 14, 2021·Movement Disorders Clinical Practice·Sanjay Pandey, Laxmikant Ramkumarsingh Tomar
Jun 8, 2021·Applied Biochemistry and Biotechnology·Jin-Ling YangKai-Li Ma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Silke Appel-CresswellMatthew J Farrer
Movement Disorders : Official Journal of the Movement Disorder Society
Antonio E EliaEnza Maria Valente
Parkinsonism & Related Disorders
Shinsuke FujiokaZbigniew K Wszolek
© 2021 Meta ULC. All rights reserved